Yarlagadda S. Babu
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Yarlagadda S. Babu
The proxy statement of Biocryst Pharmaceuticals Inc reports total compensation of $2,565,782 for Yarlagadda S. Babu in fiscal 2022, including a base salary of $483,000. Disclosed compensation is on record for 5 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Biocryst Pharmaceuticals Inc (BCRX)
Proxy statement
Start not stated–2023-04-27
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Biocryst Pharmaceuticals Inc (BCRX) | Chief Discovery Officer | $483,000 | $2,565,782 |
| 2021 | Biocryst Pharmaceuticals Inc (BCRX) | Chief Discovery Officer | $458,945 | $2,386,139 |
| 2020 | Biocryst Pharmaceuticals Inc (BCRX) | Chief Discovery Officer | $445,578 | $2,264,785 |
| 2019 | Biocryst Pharmaceuticals Inc (BCRX) | Chief Discovery Officer | $432,600 | $1,083,307 |
| 2018 | Biocryst Pharmaceuticals Inc (BCRX) | Chief Discovery Officer | $420,000 | $1,755,510 |
Recent activity
No call appearances or filed executive changes recorded yet.